Esophageal Cancer News

Esophageal Cancer Care: From Siloed to Seamless - School of Medicine | University of Utah

Esophageal Cancer Care: From Siloed to Seamless School of Medicine | University of Utah

Esophageal Cancer Clinical Trial Pipeline Accelerates as 80+ - openPR.com

Esophageal Cancer Clinical Trial Pipeline Accelerates as 80+ openPR.com

Spotting and treating esophageal cancer: The best practices in 2026 - Action News Jax

Spotting and treating esophageal cancer: The best practices in 2026 Action News Jax

Surgical Treatment of Esophageal Cancer — The Advent of the Era of Individualization - The New England Journal of Medicine

Surgical Treatment of Esophageal Cancer — The Advent of the Era of Individualization The New England Journal of Medicine

Understanding Stage 4 Esophageal Cancer - Mass General Brigham

Understanding Stage 4 Esophageal Cancer Mass General Brigham

A Clinical Trial Successfully Treated Norm Krimbill’s Metastatic Esophageal Cancer Without Surgery or Radiation - CU Anschutz newsroom

A Clinical Trial Successfully Treated Norm Krimbill’s Metastatic Esophageal Cancer Without Surgery or Radiation CU Anschutz newsroom

Researchers discover genetic link to Barrett’s esophagus offering new hope for esophageal cancer patients - Case Western Reserve University

Researchers discover genetic link to Barrett’s esophagus offering new hope for esophageal cancer patients Case Western Reserve University

FDA Approves Adding Durvalumab Immunotherapy to Prevent Stomach and Esophageal Cancer Recurrence - Memorial Sloan Kettering Cancer Center

FDA Approves Adding Durvalumab Immunotherapy to Prevent Stomach and Esophageal Cancer Recurrence Memorial Sloan Kettering Cancer Center

Risk factors for postoperative pulmonary complications in esophageal cancer: focus on inflammatory markers - Frontiers

Risk factors for postoperative pulmonary complications in esophageal cancer: focus on inflammatory markers Frontiers

Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data - Nature

Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data Nature

10 years after proton therapy, an esophageal cancer patient is thriving - Fred Hutchinson Cancer Center

10 years after proton therapy, an esophageal cancer patient is thriving Fred Hutchinson Cancer Center

Lipid droplet clearance inhibits esophageal cancer growth via metabolic reprogramming - ScienceDirect.com

Lipid droplet clearance inhibits esophageal cancer growth via metabolic reprogramming ScienceDirect.com

Treat the Tumor, Spare the Esophagus: The Case for Organ Preservation in Locally Advanced Esophageal/Gastroesophageal Junction Cancer - ASCO Publications

Treat the Tumor, Spare the Esophagus: The Case for Organ Preservation in Locally Advanced Esophageal/Gastroesophageal Junction Cancer ASCO Publications

Esophageal Cancer and Smoking: What You Need to Know To Protect Yourself? - Oncodaily

Esophageal Cancer and Smoking: What You Need to Know To Protect Yourself? Oncodaily

Palliative Radiotherapy for Dysphagia in Esophageal Cancer: Short-Term Benefits and Late Toxicity Risks - Cureus

Palliative Radiotherapy for Dysphagia in Esophageal Cancer: Short-Term Benefits and Late Toxicity Risks Cureus

Pulsed Low-Dose–Rate Chemoradiation Reduces Severe Esophagitis in Esophageal Cancer and NSCLC - The ASCO Post

Pulsed Low-Dose–Rate Chemoradiation Reduces Severe Esophagitis in Esophageal Cancer and NSCLC The ASCO Post

A Major Study Examines Endoscopies that Fail to Detect Esophageal Cancer - CU Anschutz newsroom

A Major Study Examines Endoscopies that Fail to Detect Esophageal Cancer CU Anschutz newsroom

Personalized intensity modulation radiation therapy auto-planning for esophageal cancer - Nature

Personalized intensity modulation radiation therapy auto-planning for esophageal cancer Nature

The tumor microenvironment in esophageal cancer and its association with clinical features and neoadjuvant treatment response - Nature

The tumor microenvironment in esophageal cancer and its association with clinical features and neoadjuvant treatment response Nature

Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial - Nature

Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial Nature

How Smoking Affects Esophageal Cancer Risk - Gastroenterology Advisor

How Smoking Affects Esophageal Cancer Risk Gastroenterology Advisor

Study demonstrates proof of concept for preventing esophageal cancer - Medical Xpress

Study demonstrates proof of concept for preventing esophageal cancer Medical Xpress

Understanding Esophageal Cancer - AdventHealth

Understanding Esophageal Cancer AdventHealth

A high-power spatial, single-cell view of pericytes in esophageal cancer metastasis - Nature

A high-power spatial, single-cell view of pericytes in esophageal cancer metastasis Nature

Study on the survival prognosis of over 80 years old patients of esophageal cancer with other cancers-based on SEER data analysis - Nature

Study on the survival prognosis of over 80 years old patients of esophageal cancer with other cancers-based on SEER data analysis Nature

Multi-analyte liquid biopsy approaches for early detection of esophageal cancer: the expanding role of ctDNA - Frontiers

Multi-analyte liquid biopsy approaches for early detection of esophageal cancer: the expanding role of ctDNA Frontiers

Norton Healthcare first in Louisville to unveil new treatment for esophageal cancer - Norton Healthcare

Norton Healthcare first in Louisville to unveil new treatment for esophageal cancer Norton Healthcare

New Treatment Strategies for Esophageal Cancer - American Association for Cancer Research (AACR)

New Treatment Strategies for Esophageal Cancer American Association for Cancer Research (AACR)

Detectable ctDNA Potential Predictor of Gastroesophageal, Esophageal Cancer Recurrence - AJMC

Detectable ctDNA Potential Predictor of Gastroesophageal, Esophageal Cancer Recurrence AJMC

ID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression - Nature

ID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression Nature

Man, 40, Reveals the First Sign He Had Esophageal Cancer That His Doctor Dismissed - TODAY.com

Man, 40, Reveals the First Sign He Had Esophageal Cancer That His Doctor Dismissed TODAY.com

Environmental exposure to perfluorooctane sulfonate and its role in esophageal cancer progression: a comprehensive bioinformatics and experimental study - Nature

Environmental exposure to perfluorooctane sulfonate and its role in esophageal cancer progression: a comprehensive bioinformatics and experimental study Nature

Therapeutic outcomes of different treatment approaches for T1a-M3/T1b esophageal cancer and development of a prognostic prediction model - Nature

Therapeutic outcomes of different treatment approaches for T1a-M3/T1b esophageal cancer and development of a prognostic prediction model Nature

Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications - Nature

Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications Nature

Case Report: The huge esophageal displacement: a case of dramatic esophageal interfraction motion during neoadjuvant chemotherapy and immunotherapy - Frontiers

Case Report: The huge esophageal displacement: a case of dramatic esophageal interfraction motion during neoadjuvant chemotherapy and immunotherapy Frontiers

Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116 - Nature

Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116 Nature